Intuniv vs. Adderall XR
See how Intuniv and Adderall XR compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Intuniv is a non-stimulant approved for ADHD in children and teens, while Adderall XR is a stimulant approved for both children and adults.
Intuniv can be added to a stimulant for extra symptom control, while Adderall XR carries a boxed warning for abuse, misuse, and addiction risk.
Both are taken once daily, but Intuniv needs a multi-week titration schedule while Adderall XR reaches an effective dose more quickly.
Intuniv vs. Adderall XR Drug Summary
Intuniv
Intuniv is a non-stimulant medication that activates alpha2A receptors in the brain to improve attention and impulse control. It is FDA-approved for ADHD in children and adolescents ages 6 to 17, used alone or added to a stimulant. It comes as an extended-release tablet taken once daily, morning or evening.
Adderall XR
Adderall XR is an extended-release stimulant containing a mix of amphetamine salts that raise dopamine and norepinephrine activity in the brain. It is FDA-approved for ADHD in children age 6 and older, adolescents, and adults, unlike Intuniv, which is not approved for adults. It is taken once daily as an extended-release capsule and is a Schedule II controlled substance.
Intuniv vs. Adderall XR Side Effects
Intuniv
Adderall XR
Intuniv vs. Adderall XR Dosage
Intuniv
Adderall XR
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | Week 1 |
| Maximum dose | 4 mg once daily | Week 4 onward |
| Dose changes | 3 increases | Every week |
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | At the start |
| Maximum dose | 10 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Intuniv
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | Week 1 |
| Maximum dose | 4 mg once daily | Week 4 onward |
| Dose changes | 3 increases | Every week |
Adderall XR
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | At the start |
| Maximum dose | 10 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Intuniv vs. Adderall XR Indications
Intuniv
Intuniv is FDA-approved for ADHD in children and adolescents ages 6 to 17, either as a standalone treatment or added to a stimulant regimen. It is not approved for adults, though doctors sometimes prescribe it off-label for adult ADHD.
Monotherapy for ADHD in ages 6-17
Adjunctive therapy with stimulants, ages 6-17
Off-label use in adults (not FDA-approved)
Adderall XR
Adderall XR is FDA-approved for ADHD in children ages 6 and older, adolescents, and adults, covering the full age range. It is not approved for children under 6 or for patients with end-stage renal disease.
ADHD treatment in children age 6 and older
ADHD treatment in adolescents
ADHD treatment in adults
Intuniv vs. Adderall XR Pros and Cons
Intuniv
Intuniv works gradually through a non-stimulant mechanism, making it an option for families who want to avoid stimulant side effects or add it to an existing stimulant regimen. It requires a step-up dosing schedule and a taper when stopping, and it is only approved for children and teens.
Pros
Non-stimulant option with no abuse potential or controlled-substance status
Can be combined with a stimulant for added symptom control
No boxed warning for abuse, misuse, or addiction
Cons
Requires several weeks of titration before reaching a maintenance dose
Not approved for adults, limiting use once a patient ages out of adolescence
Common side effects include sedation, low blood pressure, and slowed heart rate
Abrupt stopping can cause rebound high blood pressure, requiring a taper
Adderall XR
Adderall XR acts quickly as a stimulant and is approved across the full age range from childhood through adulthood, but it carries a boxed warning for abuse potential and added cardiovascular precautions. Its once-daily dosing is straightforward, without the multi-week titration Intuniv requires.
Pros
Approved for the full ADHD age range, including adults
Reaches an effective dose faster, with fewer dose-adjustment steps
Long track record since 2001 across children, teens, and adults
Cons
Schedule II controlled substance with a boxed warning for abuse, misuse, and addiction
Carries cardiovascular warnings, including sudden death in structural heart defects
Can cause appetite suppression and growth suppression with long-term pediatric use
Not recommended with amphetamine hypersensitivity or recent MAOI use
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.